Last updated: 22 July 2019 at 2:39pm EST

Nicholas J Iii Simon Net Worth




The estimated Net Worth of Nicholas J Iii Simon is at least $65 Milión dollars as of 31 August 2004. Nicholas Simon owns over 85,027 units of Rigel Pharmaceuticals stock worth over $21,881,324 and over the last 21 years Nicholas sold RIGL stock worth over $43,070,700.

Nicholas Simon RIGL stock SEC Form 4 insiders trading

Nicholas has made over 18 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Nicholas sold 868,055 units of RIGL stock worth $20,390,612 on 23 November 2004.

The largest trade Nicholas's ever made was selling 868,055 units of Rigel Pharmaceuticals stock on 23 November 2004 worth over $20,390,612. On average, Nicholas trades about 92,598 units every 13 days since 2004. As of 31 August 2004 Nicholas still owns at least 1,687,072 units of Rigel Pharmaceuticals stock.

You can see the complete history of Nicholas Simon stock trades at the bottom of the page.



What's Nicholas Simon's mailing address?

Nicholas's mailing address filed with the SEC is 6300 Dumbarton Cir, Fremont, CA 94555, USA.

Insiders trading at Rigel Pharmaceuticals

Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke a Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.



What does Rigel Pharmaceuticals do?

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.



Complete history of Nicholas Simon stock trades at Rigel Pharmaceuticals

Človek
Trans.
Transakcia
Celková cena
Nicholas J Iii Simon
Riaditeľ
Predaj $20,390,612
23 Nov 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $483,527
17 Sep 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $1,764,310
31 Aug 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $729,580
19 Aug 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $422,918
17 Aug 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $223,000
13 Aug 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $45,543
28 Jun 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $1,946,648
24 Jun 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $468,293
22 Jun 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $36,540
2 Jun 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $250,542
28 May 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $464,108
26 May 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $57,255
24 May 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $2,403,149
20 May 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $3,286,636
19 Apr 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $6,303,899
8 Apr 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $346,680
19 Mar 2004
Nicholas J Iii Simon
Riaditeľ
Predaj $3,447,460
19 Feb 2004


Rigel Pharmaceuticals executives and stock owners

Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: